journal
https://read.qxmd.com/read/37977953/diagnostic-work-up-of-hematological-malignancies-with-underlying-germline-predisposition-disorders-gpd
#21
REVIEW
Rashmi Kanagal-Shamanna, Kristian T Schafernak, Katherine R Calvo
Hematological malignancies with underlying germline predisposition disorders have been recognized by the World Health Organization 5th edition and International Consensus Classification (ICC) classification systems. The list of genes and the associated phenotypes are expanding and involve both pediatric and adult populations. While the clinical presentation and underlying molecular pathogenesis are relatively well described, the knowledge regarding the bone marrow morphologic features, the landscape of somatic aberrations associated with progression to hematological malignancies is limited...
November 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37953192/updates-on-lymphoblastic-leukemia-lymphoma-classification-and-minimal-measurable-residual-disease-analysis
#22
REVIEW
Alexandra E Kovach, Brent L Wood
Lymphoblastic leukemia/lymphoma (ALL/LBL), especially certain subtypes, continues to confer morbidity and mortality despite significant therapeutic advances. The pathologic classification of ALL/LBL, especially that of B-ALL, has recently substantially expanded with the identification of several distinct and prognostically important genetic drivers. These discoveries are reflected in both current classification systems, the World Health Organization (WHO) 5th edition and the new International Consensus Classification (ICC)...
November 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37507252/inherited-bone-marrow-failure-syndromes-and-germline-predisposition-to-myeloid-neoplasia-a-practical-approach-for-the-pathologist
#23
REVIEW
Jingwei Li, Jacob R Bledsoe
The diagnostic work up and surveillance of germline disorders of bone marrow failure and predisposition to myeloid malignancy is complex and involves correlation between clinical findings, laboratory and genetic studies, and bone marrow histopathology. The rarity of these disorders and the overlap of clinical and pathologic features between primary and secondary causes of bone marrow failure, acquired aplastic anemia, and myelodysplastic syndrome may result in diagnostic uncertainty. With an emphasis on the pathologist's perspective, we review diagnostically useful features of germline disorders including Fanconi anemia, Shwachman-Diamond syndrome, telomere biology disorders, severe congenital neutropenia, GATA2 deficiency, SAMD9/SAMD9L diseases, Diamond-Blackfan anemia, and acquired aplastic anemia...
November 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37451943/classic-hodgkin-lymphoma-in-young-people
#24
REVIEW
Srishti Gupta, Jeffrey W Craig
Classic Hodgkin lymphoma (CHL) is a unique form of lymphoid cancer featuring a heterogeneous tumor microenvironment and a relative paucity of malignant Hodgkin and Reed-Sternberg (HRS) cells with characteristic phenotype. Younger individuals (children, adolescents and young adults) are affected as often as the elderly, producing a peculiar bimodal age-incidence profile that has generated immense interest in this disease and its origins. Decades of epidemiological investigations have documented the populations most susceptible and identified multiple risk factors that can be broadly categorized as either biological or environmental in nature...
November 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37295994/reactive-lymphadenopathy-in-the-pediatric-population-with-a-focus-on-potential-mimics-of-lymphoma
#25
REVIEW
Rachel A Mariani, Elizabeth L Courville
Benign lymphadenopathy is common in the pediatric population and may be clinically striking. As in adults, lymph node evaluation in pediatric patients requires careful morphologic and immunohistochemical assessment and clinical contextualization of the findings. It is important for the pathologist to be familiar with benign and reactive conditions that may mimic malignancy. This review presents non-neoplastic or indolent processes or patterns of lymphoid hyperplasia that may be confused with or raise the differential of lymphoma, with a focus on those more commonly encountered in the pediatric/adolescent population...
November 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37258365/the-changing-landscape-of-pediatric-histiocytoses-birth-life-and-transdifferentiation-of-pediatric-histiocytes
#26
REVIEW
Aaron Auerbach, Nadine S Aguilera
Histiocytic neoplasms in the children are very rare, and histiocytoses can occur in the perinatal period. The presumed origins and presentation of specific histiocytoses in the pediatric age group are described. Common and newly described histiocytoses are presented including Langerhans cell histiocytosis, Rosai-Dorfman disease, histiocytic sarcoma, ALK positive histiocytosis, and hemophagocytic lymphohistiocytosis. Molecular findings common to pediatric histiocytoses are also discussed.
November 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37993384/pathology-of-hereditary-renal-cell-carcinoma-syndromes-tuberous-sclerosis-complex-tsc
#27
REVIEW
Miranda E Machacek, Chin-Lee Wu, Kristine M Cornejo
Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disease characterized by hamartomatous tumors involving multiple organs such as the brain, skin, heart, lung and kidney. TSC is caused by inactivating mutations in TSC1/TSC2, which encodes hamartin and tuberin, respectively, and forms a complex that regulates mechanistic target of rapamycin complex 1 (mTORC1), resulting in cell overgrowth and oncogenesis. Since a leading cause of morbidity and mortality in TSC relates to chronic kidney disease and the ability to preserve renal function, this review describes the important pathologic findings in TSC-associated renal neoplasms and their correlating sporadic counterparts...
September 20, 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37453847/small-biopsies-in-the-head-and-neck-bone-and-soft-tissue
#28
REVIEW
Aarti E Sharma, Darcy A Kerr, Nicole A Cipriani
Bone and soft tissue lesions in the head and neck encompass not only a broad morphologic spectrum but also significant inherent clinicopathologic overlap. Epidemiology, radiology, and location - similar to the diagnostic assessment in other sites - are especially important considerations in the context of an established mesenchymal proliferation. Herein, the approach towards diagnosis is stratified by morphology (spindle, sarcomatoid, epithelioid, round cell), cellular lineage (fibroblastic, nerve sheath, rhabdomyogenic), and tumor grade (benign, low- to high-grade malignant) as the basis of further immunohistochemical or molecular investigation...
September 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37391302/approach-to-small-biopsies-in-the-larynx
#29
REVIEW
Abberly Lott Limbach
Small biopsies in the larynx can make a definitive diagnosis challenging due to the sampling or tangential sectioning. The differential diagnosis can be divided into mucosal lesions (squamous papillomas, intraepithelial dysplasia, and invasive squamous cell carcinoma) or submucosal lesions (vocal cord polyps/nodules, amyloidosis, granular cell tumor, rhabdomyoma, neuroendocrine neoplasms, salivary gland tumors, and cartilaginous tumors). Diagnostic criteria (both morphologic and immunohistochemical) are reviewed to arrive at a diagnosis even on small biopsy...
September 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37173165/indeterminate-thyroid-nodules-and-advances-in-molecular-pathology
#30
REVIEW
Brendan Belovarac, Fang Zhou, Jake Sharma, Tamar C Brandler
Thyroid cytology has in recent years been augmented by molecular testing for indeterminate lesions. Three commercial molecular tests are available which provide variable amounts of detail regarding the genetic alterations identified in a sample. This paper will describe these tests, as well as the common molecular drivers associated with papillary thyroid carcinoma (PTC) and follicular patterned lesions, in order to help the practicing pathologist and clinician better interpret the results of these tests and incorporate this information into their management of cytologically indeterminate thyroid lesions...
September 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37596187/post-transplant-lymphoproliferative-disorders-ptld-in-adolescents-and-young-adults-a-category-in-need-of-definition
#31
REVIEW
Amy Chadburn
Post-transplant lymphoproliferative disorders are a well-recognized complication of solid organ and stem cell transplantation. Much data has accumulated with respect to the pathobiology and clinical behavior of these lesions in the general post-transplant population as well as in the pediatric and adult age groups. However, information as to these lesions in the adolescent and young adult populations, which bridge the pediatric and adult groups, is limited. In this review, the focus is on this unique population of PTLD patients and their proliferations...
August 1, 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37479638/a-personalized-approach-to-lymphoproliferations-in-patients-with-inborn-errors-of-immunity
#32
REVIEW
Shachar Naor, Etai Adam, Ginette Schiby, Dita Gratzinger
Biopsies from patients with inborn error of immunity (IEI) may pose a diagnostic challenge due to the abnormal anatomy of their lymphoid organs and the tendency for the development of lymphoproliferations in various organs, some of which may lead to the wrong impression of malignant lymphoma which may prompt aggressive unnecessary treatment. In this article we will review typical histologic findings in various IEI's described in the literature and discuss the appropriate approach to the diagnosis of lymphoproliferations in these patients by presenting illustrative cases...
July 11, 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37438163/the-many-faces-of-atypical-fibroxanthoma
#33
REVIEW
Abbas Agaimy
Atypical fibroxanthoma (AFX) is an uncommon, primary dermal neoplasm of uncertain histogenesis, typically originating in the sun-damage skin of the head and neck of the elderly. Since first description in 1958, ∼3000 cases have been reported in the literature. However, the disease is underreported as the neoplasm is considered a standard diagnosis in the last decades. On the other hand, many earlier reports likely have included non-AFX mimics or aggressive pleomorphic dermal sarcomas. In contrast to its alarming high-grade histology, AFX behaves indolently with rare recurrences/ metastatic rate of <2%...
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37156707/gene-fusions-in-superficial-mesenchymal-neoplasms-emerging-entities-and-useful-diagnostic-adjuncts
#34
REVIEW
Grant M Fischer, David J Papke
Cutaneous mesenchymal neoplasms are diagnostically challenging because of their overlapping morphology, and, often, the limited tissue in skin biopsy specimens. Molecular and cytogenetic techniques have identified characteristic gene fusions in many of these tumor types, findings that have expanded our understanding of disease pathogenesis and motivated development of useful ancillary diagnostic tools. Here, we provide an update of new findings in tumor types that can occur in the skin and superficial subcutis, including dermatofibrosarcoma protuberans, benign fibrous histiocytoma, epithelioid fibrous histiocytoma, angiomatoid fibrous histiocytoma, glomus tumor, myopericytoma/myofibroma, non-neural granular cell tumor, CIC-rearranged sarcoma, hybrid schwannoma/perineurioma, and clear cell sarcoma...
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37150655/an-update-on-selected-cutaneous-myo-fibroblastic-mesenchymal-tumors
#35
REVIEW
Natalia Georgantzoglou, Konstantinos Linos
Cutaneous (myo)fibroblastic tumors constitute a group of tumors with overlapping clinicopathological features and variable biologic behavior. In the present review we focus on the histomorphology, immunohistochemical profile and molecular background of the following entities: dermatofibrosarcoma protuberans (DFSP), CD34-positive fibroblastic tumor (SCD34FT), myxoinflammatory sarcoma (MIFS), low-grade myofibroblastic sarcoma, solitary fibrous tumor and nodular fasciitis. Although some of these entities typically arise in deep-seated locations, they may occasionally present as cutaneous/superficial tumors and might be challenging to recognize...
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37149395/benign-and-low-grade-superficial-endothelial-cell-neoplasms-in-the-molecular-era
#36
REVIEW
Julio A Diaz-Perez, Darcy A Kerr
Vascular tumors are the most common mesenchymal neoplasms of the skin and subcutis, and they encompass a heterogeneous group with diverse clinical, histological, and molecular features, as well as biological behavior. Over the past two decades, molecular studies have enabled the identification of pathogenic recurrent genetic alterations that can be used as additional data points to support the correct classification of these lesions. The purpose of this review is to summarize the available data related to superficially located benign and low-grade vascular neoplasms and to highlight recent molecular advances with the role of surrogate immunohistochemistry to target pathogenic proteins as diagnostic biomarkers...
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37147159/superficial-mesenchymal-tumours-expressing-epithelial-markers-on-immunohistochemistry-diagnostic-clues-and-pitfalls
#37
REVIEW
Vanghelita Andrei, Simon Haefliger, Daniel Baumhoer
The diagnosis of mesenchymal neoplasms arising in the superficial soft tissue can be challenging as some entities are rare and show overlapping features. Moreover, the spectrum of mesenchymal tumours has expanded recently to include potential new entities, some of which have been described after the 5th edition of the World Health Organisation (WHO) classification of soft tissue and bone tumours published in 2020. In the skin and superficial soft tissue, tumours of epidermal, melanocytic and appendageal origin are more commonly encountered than mesenchymal neoplasms...
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37121782/contemporary-diagnostic-approach-to-atypical-vascular-lesion-and-angiosarcoma
#38
REVIEW
Cooper D Rutland, Gregory R Bean, Gregory W Charville
Vascular neoplasms account for a substantial fraction of cutaneous mesenchymal tumors, spanning from clinically indolent benign lesions to highly aggressive malignancies. These neoplasms present a distinctive challenge in terms of their diagnostic histopathology, both because of the breadth of their morphological manifestations and because of the significant histological overlap between different entities, even benign and malignant ones. The post-radiotherapy setting is particularly problematic diagnostically, insofar as radiation exposure predisposes not only to secondary angiosarcoma, but also to atypical vascular lesion, a largely benign proliferation of cutaneous blood vessels typically affecting the breast...
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37120349/the-new-and-old-in-superficial-mesenchymal-tumors-with-uncertain-origin-and-or-melanocytic-differentiation
#39
REVIEW
Ahmad Alkashash, Azadeh Samiei, Ahmed K Alomari
No abstract text is available yet for this article.
July 2023: Seminars in Diagnostic Pathology
https://read.qxmd.com/read/37120348/application-of-immunohistochemical-studies-in-diagnosing-emerging-superficial-mesenchymal-neoplasms
#40
REVIEW
Kasey J McCollum, Rami N Al-Rohil
Molecular diagnostics, with the subsequent development of novel immunohistochemical markers, continues to advance and expand the field of soft tissue pathology. As such, the ever-evolving molecular diagnostic landscape will continue to shape and refine our understanding and classification of neoplasms. This article reviews the current literature on various tumors of mesenchymal origin, including fibroblastic/fibrohistiocytic, adipocytic, vascular, and tumors of uncertain origin. We aim to give the reader a detailed understanding and pragmatic approach to various new and established immunohistochemical stains in diagnosing these neoplasms and also discuss various pitfalls with significant repercussions...
July 2023: Seminars in Diagnostic Pathology
journal
journal
28973
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.